Mixed Phenotype Acute Leukemia: Clinical Trials

25 trials for Mixed Phenotype Acute Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 recruiting, 5 completed, 4 active not recruiting, 1 not yet recruiting. 25 Phase 2, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 225Recruiting 13, Completed 5, Active not recruiting 4, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 111Recruiting 8, Active not recruiting 1, Completed 1, Unknown 1

Follow Mixed Phenotype Acute Leukemia: new trials by email Literature Review of Mixed Phenotype Acute Leukemia trials Research Report on Mixed Phenotype Acute Leukemia

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Not yet recruitingFred Hutchinson Cancer Center522027-01-012026-09-14
A Study of Revumenib and Mezigdomide in People With Leukemia
Revumenib, Mezigdomide - Leukemia, Acute Leukemia
Phase 1 / Phase 2RecruitingMemorial Sloan Kettering Cancer Center522026-01-162026-10-20
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca-T - Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Phase 2RecruitingOrca Biosystems, Inc.802025-12-092026-07-07
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Acute Undifferentiated Leukemia
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center362025-09-232026-05-15
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Dose Level 1, VNX-101, Dose Level 2, VNX-101, Dose Level 3, VNX-101 - B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma
Phase 1 / Phase 2RecruitingVironexis Biotherapeutics Inc.322025-05-302026-10-26
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Donor-derived Natural Killer Cell - Acute Myeloid Leukemia, Acute Lymphoblastic T-cell Leukemia
Phase 2RecruitingFederal Research Institute of Pediatric Hematology, Oncology and Immunology152025-05-092025-12-01
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Dexamethasone, Vincristine, Daunorubicin - T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma
Phase 2RecruitingSt. Jude Children's Research Hospital1002024-12-272026-08-10
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center542024-07-232026-10-26
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Orca-Q - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 1 / Phase 2RecruitingUniversity of Florida402022-08-162026-10-30
Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Azacitidine, Venetoclax, Flumatinib - Philadelphia Chromosome, Acute Myeloid Leukemia
Phase 2CompletedThe First Affiliated Hospital of Soochow University202022-05-012024-04-25
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Biospecimen Collection - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2RecruitingPedAL BCU, LLC9602022-04-182026-08-25
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Cladribine, Cytarabine, Mitoxantrone - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2RecruitingUniversity of Washington622022-02-042026-11-06
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Busulfan, Fludarabine, Total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Phase 2Active not recruitingCenter for International Blood and Marrow Transplant Research3002021-09-302026-03-18
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia
Humanized CD7 CAR-T cells - T Lymphoblastic Leukemia/Lymphoma, Mixed Phenotype Acute Leukemia
Phase 1 / Phase 2UnknownThe First Affiliated Hospital of Soochow University202021-06-012021-06-02
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Leukemia, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center602021-01-252026-05-29
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting
Azacitidine, Venetoclax - Acute Bilineal Leukemia, Acute Biphenotypic Leukemia
Phase 2Active not recruitingM.D. Anderson Cancer Center1002020-05-052026-10-05
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
revumenib, cobicistat - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1 / Phase 2RecruitingSyndax Pharmaceuticals4472019-11-052026-10-09
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Ziftomenib, Midazolam, Itraconazole - Advanced Malignant Neoplasm, Acute Myeloid Leukemia
Phase 1 / Phase 2Active not recruitingKura Oncology, Inc.2632019-09-122026-05-13
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Total-Body Irradiation, Thiotepa, Fludarabine - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Active not recruitingFred Hutchinson Cancer Center452019-08-292026-09-25
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
Decitabine, Laboratory Biomarker Analysis, Venetoclax - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2TerminatedM.D. Anderson Cancer Center2352018-01-182026-03-10

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Leukemia, Biphenotypic, Acute (25)  ·  Leukemia, Myeloid, Acute (20)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (13)  ·  Myelodysplastic Syndromes (9)  ·  Leukemia (7)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (6)  ·  Burkitt Lymphoma (5)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Leukemia, Myelomonocytic, Chronic (4)  ·  Lymphoma (4)  ·  Hematologic Neoplasms (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Mantle-Cell (3)

Broader conditions

Hemic and Lymphatic Diseases (25)  ·  Leukemia, Lymphoid (24)  ·  Lymphatic Diseases (24)  ·  Lymphoproliferative Disorders (24)  ·  Hematologic Diseases (23)  ·  Immune System Diseases (23)  ·  Immunoproliferative Disorders (23)  ·  Neoplasms (23)  ·  Neoplasms by Histologic Type (23)  ·  Leukemia, Myeloid (19)  ·  Leukemia (18)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Bone Marrow Diseases (11)  ·  Chronic Disease (11)  ·  Disease Attributes (11)

Interventions

Cyclophosphamide (8)  ·  Whole-Body Irradiation (8)  ·  Cytarabine (6)  ·  Mycophenolic Acid (5)  ·  Specimen Handling (5)  ·  fludarabine (5)  ·  fludarabine phosphate (5)  ·  venetoclax (5)  ·  Cyclosporine (4)  ·  Cyclosporins (4)  ·  Azacitidine (3)  ·  Calcium Dobesilate (3)  ·  Decitabine (3)  ·  Dexamethasone (3)  ·  Filgrastim (3)

Sponsors

Fred Hutchinson Cancer Center (8)  ·  M.D. Anderson Cancer Center (3)  ·  The First Affiliated Hospital of Soochow University (2)  ·  Center for International Blood and Marrow Transplant Research (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Kura Oncology, Inc. (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Orca Biosystems, Inc. (1)  ·  PedAL BCU, LLC (1)  ·  St. Jude Children's Research Hospital (1)  ·  Syndax Pharmaceuticals (1)  ·  University of Florida (1)  ·  University of Washington (1)  ·  Vironexis Biotherapeutics Inc. (1)

Countries

United States (22)  ·  Canada (4)  ·  Australia (3)  ·  Puerto Rico (3)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  Belgium (1)  ·  Israel (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Russia (1)

Top investigators

Phuong Vo, MD (2)  ·  Abhishek Maiti, MBBS (1)  ·  Angela R Smith, M.D. (1)  ·  Ann Dahlberg (1)  ·  Betul Oran (1)  ·  Brenda M. Sandmaier (1)  ·  Elias Jabbour (1)  ·  Jordan Milner, MD (1)  ·  Kuo-Kai Chin, MD (1)  ·  Marie Bleakley (1)  ·  Mary-Beth M. Percival (1)  ·  Michele S Redell (1)  ·  Naveed Ali, MD (1)  ·  Rachel Salit (1)  ·  Rishi S Kotecha (1)

Results publications

PMID 33741715, PMID 34267079, PMID 30335787, PMID 32077361, PMID 32896301, PMID 33027528, PMID 33049057, PMID 33580980, PMID 33792630, PMID 34255353, PMID 34474640, PMID 36175988, PMID 36922593, PMID 38867582, PMID 39121437, PMID 39362248, PMID 40332046, PMID 40523209, PMID 40535475, PMID 40997296, PMID 41619724, PMID 41621809, PMID 42448319, PMID 42616616

NIH funding

P30CA015704 (3), U10CA180886 (2), P01CA018029 (1), P01CA078902 (1)